A study led by Dr. Sascha Dublin finds similar outcomes for 3 hypertension medications, filling an evidence gap.
Participant in KPWHRI trial has first-ever injection of SchistoShield vaccination.
A team led by KPWHRI's Kai Yeung, PharmD, PhD, reviewed trial results for cost-effectiveness of 3 treatments.
We study health and health care as it happens in everyday settings by everyday people, producing results that are built to work in the real world. We share our results in the public domain to benefit people everywhere.